German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004).
The availability and application of effective antiretroviral combination therapies have now almost become routine. More than 20 antiretroviral substances in four classes have been approved. Although an almost incalculable number of combinations can be conceived, it must be stressed, that only a small number of the theoretically possible combinations are actually applicable. As a result of the broad therapeutic armamentarium, HIV infection can be better treated. However, the decisions to start, monitor and change therapy have become even more difficult because the indication for treatment, the selection of the most suitable therapy for an individual, the information and counselling of the patient, and the monitoring of the success of treatment all demand a high level of knowledge and experience. This guideline evaluates the indication and selection of the initial antiretroviral therapy for HIV infection.
Salzberger
B
B
Klinik für Dermatologie und Allergologie der Ruhr-Universität, Gudrunstrasse 56, D-44791 Bochum, Germany.
Marcus
U
U
Vielhaber
B
B
Arasteh
K
K
Gölz
J
J
Brockmeyer
N H
NH
Rockstroh
J
J
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D001317:Austria; D005858:Germany; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects; D006801:Humans
D044966:Anti-Retroviral Agents